Just a few months after buying Timber Pharma, LEO Pharma has revealed that the main drug it acquired as part of the deal has failed a phase 3 trial. Timber's lead candidate TMB-001 for rare skin ...
ETHealthworld.com brings latest ministry of health and family welfare news, views and updates from all top sources for the Indian Health industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback